Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children
- PMID: 33810963
- DOI: 10.1016/j.numecd.2021.01.020
Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children
Abstract
Background and aim: The association between non-alcoholic fatty liver (NAFL) and the variant rs641738 within the membrane bound O-acyltransferase domain-containing 7 (MBOAT7) gene is currently uncertain, especially in the paediatric population. We examined whether there is an association between this genetic variant and NAFL in a large multicentre, hospital-based cohort of Italian overweight/obese children.
Methods and results: We studied 1760 overweight or obese children [mean age (SD): 11.1(2.9) years, z-body mass index (zBMI) 3.2(0.9)], who underwent ultrasonography for the diagnosis of NAFL. A subgroup of these children (n = 182) also underwent liver biopsy. Genotyping of the MBOAT7 rs641738 polymorphism was performed by TaqMan-Based RT-PCR system in each subject. Overall, 1131 (64.3%) children had ultrasound-detected NAFL; 528 (30%) had rs641738 CC genotype, 849 (48.2%) had rs641738 CT genotype, and 383 (21.8%) had rs641738 TT genotype, respectively. In the whole cohort, the interaction of MBOAT7 genotypes with zBMI was not associated with NAFL after adjustment for age, sex, serum triglycerides, serum alanine aminotransferase levels and patatin-like phospholipase domain-containing protein-3 (PNPLA3) genotype (adjusted-odds ratio 1.02 [95% CI 0.98-1.06]). Similarly, no association was found between MBOAT7 genotypes and NAFL after stratification by obesity status. MBOAT7 genotypes were not associated with the presence of non-alcoholic steatohepatitis or the stage of liver fibrosis in a subgroup of 182 children with biopsy-proven NAFLD.
Conclusions: The results of this study did not show any significant contribution of MBOAT7 rs641738 polymorphism to the risk of having either NAFL on ultrasonography or NASH on histology in a large hospital-based cohort of Italian overweight/obese children.
Keywords: Genetics; NAFLD; Non-alcoholic fatty liver disease; Obesity; Paediatrics.
Copyright © 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The Authors have no potential conflicts of interest to disclose.
Similar articles
-
The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):69-74. doi: 10.1097/MPG.0000000000001979. J Pediatr Gastroenterol Nutr. 2018. PMID: 29601441
-
Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.Liver Int. 2018 Jul;38(7):1300-1307. doi: 10.1111/liv.13689. Epub 2018 Jan 24. Liver Int. 2018. PMID: 29314568
-
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.Gastroenterology. 2016 May;150(5):1219-1230.e6. doi: 10.1053/j.gastro.2016.01.032. Epub 2016 Feb 2. Gastroenterology. 2016. PMID: 26850495 Free PMC article.
-
Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review.Eur J Clin Invest. 2020 Oct;50(10):e13331. doi: 10.1111/eci.13331. Epub 2020 Jul 13. Eur J Clin Invest. 2020. PMID: 32589269
-
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2023 Jan;8(1):20-30. doi: 10.1016/S2468-1253(22)00317-X. Epub 2022 Nov 16. Lancet Gastroenterol Hepatol. 2023. PMID: 36400097
Cited by
-
Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis.Sci Rep. 2022 Jun 1;12(1):9157. doi: 10.1038/s41598-022-13291-1. Sci Rep. 2022. PMID: 35650387 Free PMC article.
-
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.Eur J Med Res. 2024 Mar 20;29(1):190. doi: 10.1186/s40001-024-01708-8. Eur J Med Res. 2024. PMID: 38504356 Free PMC article. Review.
-
A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health.Med Sci Monit. 2021 Aug 30;27:e934134. doi: 10.12659/MSM.934134. Med Sci Monit. 2021. PMID: 34456329 Free PMC article. Review.
-
Profiling of cell-free DNA methylation and histone signatures in pediatric NAFLD: A pilot study.Hepatol Commun. 2022 Dec;6(12):3311-3323. doi: 10.1002/hep4.2082. Epub 2022 Oct 20. Hepatol Commun. 2022. PMID: 36264206 Free PMC article.
-
Phospholipid Acyltransferases: Characterization and Involvement of the Enzymes in Metabolic and Cancer Diseases.Cancers (Basel). 2024 May 31;16(11):2115. doi: 10.3390/cancers16112115. Cancers (Basel). 2024. PMID: 38893234 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous